Cost analysis of adverse events associated with non-small cell lung cancer management in France

Cost analysis of adverse events associated with non-small cell lung cancer management in France

Christos Chouaid,1 Delphine Loirat,2 Emilie Clay,3 Aurélie Millier,3 Chloé Godard,4 Amira Fannan,4 Laurie Lévy-Bachelot,4 Eric Angevin5 1Chest Department, Centre Hospitalier Intercommunal Créteil, Créteil, France; 2Institut Curie, Paris, France;...

Full description

Bibliographic Details
Main Authors: Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Non-small cell lung cancer
Adverse events
Cost analysis
Chemotherapy
Immunotherapy.
Online Access:https://www.dovepress.com/cost-analysis-of-adverse-events-associated-with-non-small-cell-lung-ca-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-analysis-of-adverse-events-associated-with-non-small-cell-lung-ca-peer-reviewed-article-CEOR

Similar Items